Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Aratana Therapeutics Inc    PETX

ARATANA THERAPEUTICS INC

(PETX)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/10/2019 06/11/2019 06/12/2019 06/13/2019 06/14/2019 Date
4.84(c) 4.83(c) 4.9(c) 4.87(c) 4.78(c) Last
345 204 898 634 584 338 348 657 231 479 Volume
-0.62% -0.21% +1.45% -0.61% -1.85% Change
More quotes
Financials (USD)
Sales 2019 36,5 M
EBIT 2019 -17,6 M
Net income 2019 -13,9 M
Finance 2019 23,5 M
Yield 2019 -
Sales 2020 75,0 M
EBIT 2020 11,6 M
Net income 2020 8,74 M
Finance 2020 8,87 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 48,22
EV / Sales2019 5,89x
EV / Sales2020 3,06x
Capitalization 238 M
More Financials
Company
Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Company's portfolio includes therapeutic candidates in development consisting of small molecule pharmaceuticals and large molecule... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Surperformance© ratings of Aratana Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARATANA THERAPEUTICS INC
06/11ARATANA THERAPEUTICS : Granted FDA Approval of NOCITA® (bupivacaine liposome inj..
PR
06/07ARATANA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders..
AQ
06/07ARATANA THERAPEUTICS : Reports Voting Results from 2019 Annual Meeting of Stockh..
PR
05/09ARATANA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
05/08ARATANA : 1Q Earnings Snapshot
AQ
05/08ARATANA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
05/08ARATANA THERAPEUTICS : Reports First Quarter 2019 Financial Results
PR
05/07ARATANA THERAPEUTICS : to Present at Stifel 2019 Dental & Veterinary Conference
PR
05/03ARATANA INVESTOR ALERT BY THE FORMER : Kahn Swick & Foti, LLC Investigates Adequ..
BU
04/26ARATANA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulat..
AQ
More news
Analyst Recommendations on ARATANA THERAPEUTICS INC
More recommendations
Sector news : Veterinary Drugs
06/15Drug Firms Sue Over Ad Rule -- WSJ
DJ
06/14Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads
DJ
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy--Update
DJ
06/14BAYER : Deutsche Bahn to Phase out Glyphosate -WirtschaftWoche
DJ
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy
DJ
More sector news : Veterinary Drugs
Chart ARATANA THERAPEUTICS INC
Duration : Period :
Aratana Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARATANA THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 5,00 $
Spread / Average Target 2,7%
EPS Revisions
Managers
NameTitle
Craig A. Tooman President, Chief Executive Officer & Director
Wendy L. Yarno Non-Executive Chairman
Rhonda Hellums Chief Financial Officer & Treasurer
John W. Vander Vort Independent Director
Laura A. Brege Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ARATANA THERAPEUTICS INC-22.02%231
ZOETIS29.52%49 756
ELANCO ANIMAL HEALTH INC1.33%11 439
DECHRA PHARMACEUTICALS34.40%3 519
JINYU BIO-TECHNOLOGY CO LTD49.34%2 468
VIRBAC59.23%1 605